A Multicenter, Prospective, Open label, Randomized Controlled Clinical Trial to Compare the Safety and Effectiveness of the VitaSmart™ Liver Machine Perfusion System with Static Cold Storage for Organ Preservation Prior to Liver Transplantation BTL-2020-01 vs - Version 4.0 dated Sept. 23, 2021,
Role: Investigator,
Bridge to Life, Ltd,
(12/2023 - 08/2024)
Status: Completed
Post-marketing requirement study to evaluate the safety of Octaplas™ versus plasma in patients undergoing orthotopic liver transplantation with special emphasis on hyperfibrinolysis,
Role: Investigator,
Octapharma,
(06/2018 - 06/2019)
Status: Completed
Internal
Pilot investigation using HCV positive liver grafts in HCV negative or previously successfully treated recipients,
Role: Investigator,
LLU Dept. of Medicine,
(02/2022 - 02/2023)
Status: Completed
Hematologic and Immune Cell Ratios in the Prediction of Outcomes After Solid Abdominal Organ Transplantation,
Role: Investigator,
LLU Dept. of Surgery,
(07/2021)
Status: Approved
Highly Suppressive Regulatory T Cell as a Biomarker for Immunologically Relevant Delayed/Slow Graft Function after Kidney Transplantation,
Role: Investigator,
LLU Dept. of Surgery,
(10/2020)
Status: Approved
Non-Profit Organization
Integration of donor-derived cell-free DNA with HLA-DR+TNFR2+ regulatory T cell in the prediction of acute rejection and graft function after kidney transplantation,
Role: Investigator,
American Society of Transplant Surgeons,
(08/2024 - 08/2025)
Status: Approved